CenterBook Partners LP Purchases Shares of 22,054 Cardinal Health, Inc. $CAH

CenterBook Partners LP acquired a new position in Cardinal Health, Inc. (NYSE:CAH) in the second quarter, according to the company in its most recent filing with the SEC. The firm acquired 22,054 shares of the company’s stock, valued at approximately $3,705,000.

A number of other large investors have also modified their holdings of CAH. Greykasell Wealth Strategies Inc. acquired a new stake in Cardinal Health during the first quarter worth $26,000. Jones Financial Companies Lllp lifted its holdings in shares of Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after acquiring an additional 14,034 shares during the period. Atlantic Edge Private Wealth Management LLC lifted its holdings in shares of Cardinal Health by 75.0% during the 2nd quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock worth $29,000 after acquiring an additional 75 shares during the period. NewSquare Capital LLC boosted its position in shares of Cardinal Health by 100.0% during the 2nd quarter. NewSquare Capital LLC now owns 214 shares of the company’s stock valued at $36,000 after acquiring an additional 107 shares in the last quarter. Finally, AlphaCore Capital LLC bought a new stake in Cardinal Health in the second quarter valued at about $41,000. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Stock Performance

Cardinal Health stock opened at $209.27 on Friday. The business’s fifty day moving average is $171.23 and its two-hundred day moving average is $161.17. The firm has a market cap of $49.72 billion, a P/E ratio of 32.45, a P/E/G ratio of 1.39 and a beta of 0.72. Cardinal Health, Inc. has a 52 week low of $114.60 and a 52 week high of $210.32.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Thursday, October 30th. The company reported $2.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.22 by $0.33. The business had revenue of $64.01 billion during the quarter, compared to analysts’ expectations of $59.41 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The firm’s revenue for the quarter was up 22.4% compared to the same quarter last year. During the same period in the previous year, the business posted $1.88 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. On average, equities research analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be paid a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a dividend yield of 1.0%. The ex-dividend date of this dividend is Friday, January 2nd. Cardinal Health’s dividend payout ratio is 30.77%.

Wall Street Analyst Weigh In

A number of research analysts have commented on the stock. Citigroup raised their price target on shares of Cardinal Health from $165.00 to $190.00 and gave the stock a “neutral” rating in a research note on Friday, October 31st. Mizuho raised their target price on Cardinal Health from $170.00 to $210.00 and gave the stock an “outperform” rating in a research report on Monday, November 3rd. UBS Group upped their price target on Cardinal Health from $185.00 to $220.00 and gave the company a “buy” rating in a research report on Friday, October 31st. Deutsche Bank Aktiengesellschaft lifted their price objective on Cardinal Health from $195.00 to $208.00 and gave the company a “hold” rating in a report on Tuesday, November 18th. Finally, Robert W. Baird set a $232.00 target price on shares of Cardinal Health in a report on Friday, October 31st. Twelve analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $206.57.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.